Literature DB >> 9407067

Mapping and characterization of the functional domains responsible for the differential activity of the A and B isoforms of the human progesterone receptor.

P H Giangrande1, G Pollio, D P McDonnell.   

Abstract

In humans, the biological response to progesterone is mediated by two distinct forms of the progesterone receptor (human (h) PR-A, 94 kDa and hPR-B, 114 kDa). These two isoforms are transcribed from distinct estrogen-inducible promoters within a single copy PR gene; the only difference between them is that the first 164 amino acids of hPR-B (B-upstream sequence) are absent in hPR-A. In most cell lines such as MCF-7 (human breast cancer cells), CV-1 (monkey kidney fibroblasts), and HeLa (human cervical carcinoma cells), hPR-A functions as a transcriptional repressor, whereas hPR-B functions as a transcriptional activator of progesterone-responsive genes. Interestingly, in these cell contexts, hPR-A also acts as a trans-dominant repressor of the transcriptional activity of other steroid hormone receptors. In contrast to hPR-A, which functions predominantly as a ligand-dependent transcriptional repressor, we show in this study that the A isoform of the chicken PR (cPR-A) lacks this trans-dominant repressor function and is a transcriptional activator in all contexts examined. By constructing chimeras between the N-terminal domains of the chicken and human PR, we mapped the trans-dominant repressor function of hPR-A to the first 140 amino acids of the protein. Notably, when this 140-amino acid "repressor" domain is placed onto chicken PR-A, the activity of the latter changes from a transcriptional activator to a repressor. Interestingly, however, this "repressor domain" is necessary, but not sufficient, for trans-repression as it is inactive when it is tethered to a heterologous protein. This suggests that the trans-repression function is comprised not only of the repressor domain of hPR-A but also requires the context of the receptor to function. The identification of a discrete inhibitory region within hPR-A which is transferable to another receptor implies that this region interacts with a set of transcription factors or adaptors that are distinct from those recognized by hPR-B, the identification of which will be required to define the mechanism by which hPR-A modulates steroid hormone receptor transcriptional activity. Thus, although chickens and humans both produce two very similar forms of the progesterone receptor, it is clear from these studies that the mechanism of action of progesterone in these two systems is quite different.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9407067     DOI: 10.1074/jbc.272.52.32889

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  37 in total

1.  Modulation of transcriptional activation and coactivator interaction by a splicing variation in the F domain of nuclear receptor hepatocyte nuclear factor 4alpha1.

Authors:  F M Sladek; M D Ruse; L Nepomuceno; S M Huang; M R Stallcup
Journal:  Mol Cell Biol       Date:  1999-10       Impact factor: 4.272

2.  Expression and function of myometrial PSF suggest a role in progesterone withdrawal and the initiation of labor.

Authors:  Ning Xie; Liangliang Liu; Yunqing Li; Celeste Yu; Stephanie Lam; Oksana Shynlova; Martin Gleave; John R G Challis; Stephen Lye; Xuesen Dong
Journal:  Mol Endocrinol       Date:  2012-06-05

Review 3.  Progesterone receptors in mammary gland development and tumorigenesis.

Authors:  Orla M Conneely; Biserka M Jericevic; John P Lydon
Journal:  J Mammary Gland Biol Neoplasia       Date:  2003-04       Impact factor: 2.673

Review 4.  Progesterone regulation of reproductive function through functionally distinct progesterone receptor isoforms.

Authors:  Orla M Conneely; Biserka M Jericevic
Journal:  Rev Endocr Metab Disord       Date:  2002-09       Impact factor: 6.514

5.  Regulation of the structurally dynamic N-terminal domain of progesterone receptor by protein-induced folding.

Authors:  Raj Kumar; Carmen M Moure; Shagufta H Khan; Celetta Callaway; Sandra L Grimm; Devrishi Goswami; Patrick R Griffin; Dean P Edwards
Journal:  J Biol Chem       Date:  2013-08-30       Impact factor: 5.157

Review 6.  Estrogen and progesterone receptors: from molecular structures to clinical targets.

Authors:  Stephan Ellmann; Heinrich Sticht; Falk Thiel; Matthias W Beckmann; Reiner Strick; Pamela L Strissel
Journal:  Cell Mol Life Sci       Date:  2009-03-31       Impact factor: 9.261

Review 7.  Progesterone receptor signaling in the initiation of pregnancy and preservation of a healthy uterus.

Authors:  Margeaux Wetendorf; Francesco J DeMayo
Journal:  Int J Dev Biol       Date:  2014       Impact factor: 2.203

8.  Steroid receptor coactivator-2 expression in brain and physical associations with steroid receptors.

Authors:  M A Yore; D Im; L K Webb; Y Zhao; J G Chadwick; H A Molenda-Figueira; S J Haidacher; L Denner; M J Tetel
Journal:  Neuroscience       Date:  2010-06-02       Impact factor: 3.590

9.  Partial agonist activity of the progesterone receptor antagonist RU486 mediated by an amino-terminal domain coactivator and phosphorylation of serine400.

Authors:  Suzanne E Wardell; Ramesh Narayanan; Nancy L Weigel; Dean P Edwards
Journal:  Mol Endocrinol       Date:  2009-12-11

10.  Steroid receptor coactivator-1 from brain physically interacts differentially with steroid receptor subtypes.

Authors:  Heather A Molenda-Figueira; Suzanne D Murphy; Katherine L Shea; Nora K Siegal; Yingxin Zhao; Joseph G Chadwick; Larry A Denner; Marc J Tetel
Journal:  Endocrinology       Date:  2008-06-19       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.